Sherry Boschert

News

Perceived Uncontrolled Asthma in Overweight Teens May Be Deconditioning

Author:: Sherry Boschert

Publish date: April 20, 2011

Major Finding: Overweight inner-city adolescents with nonobstructive asthma were more likely than their normal-weight peers to report uncontrolled...

News

Perceived Uncontrolled Asthma in Overweight Teens May Be Deconditioning

Author:: Sherry Boschert

Publish date: April 20, 2011

Major Finding: Overweight inner-city adolescents with nonobstructive asthma were more likely than their normal-weight peers to report uncontrolled...

News

Psychotherapies for Borderline Personality Disorder Work, Slowly

Author:: Sherry Boschert

Publish date: April 19, 2011

News

Psychotherapies for Borderline Personality Disorder Work, Slowly

Author:: Sherry Boschert

Publish date: April 19, 2011

News

Collaborative Community Program Improves Asthma Care

Author:: Sherry Boschert

Publish date: April 18, 2011

News

Collaborative Community Program Improves Asthma Care

Author:: Sherry Boschert

Publish date: April 18, 2011

News

New Adenocarcinoma Classification

Author:: Sherry Boschert

Publish date: April 15, 2011

News

New Adenocarcinoma Classification

Author:: Sherry Boschert

Publish date: April 15, 2011

News

New Adenocarcinoma Classification

Author:: Sherry Boschert

Publish date: April 15, 2011

News

Perampanel Reduced Seizures by 5%-14% in Intractable Cohort

Author:: Sherry Boschert

Publish date: April 13, 2011

Major Finding: Daily adjunctive therapy with the investigational oral drug perampanel reduced the frequency of seizures by 5% using an 8-mg dose a...

News

Perampanel Reduced Seizures by 5%-14% in Intractable Cohort

Author:: Sherry Boschert

Publish date: April 13, 2011

Major Finding: Daily adjunctive therapy with the investigational oral drug perampanel reduced the frequency of seizures by 5% using an 8-mg dose a...

News

Perampanel Reduced Seizures by 5%-14% in Intractable Cohort

Author:: Sherry Boschert

Publish date: April 13, 2011

Major Finding: Daily adjunctive therapy with the investigational oral drug perampanel reduced the frequency of seizures by 5% using an 8-mg dose a...

News

Oral Laquinimod Reduced MS Relapses by 23%

Author:: Sherry Boschert

Publish date: April 13, 2011

Major Finding: Patients taking the investigational oral drug laquinimod reduced their annualized rate of multiple sclerosis relapse by 23% after 2...

News

Oral Laquinimod Reduced MS Relapses by 23%

Author:: Sherry Boschert

Publish date: April 13, 2011

Major Finding: Patients taking the investigational oral drug laquinimod reduced their annualized rate of multiple sclerosis relapse by 23% after 2...

News

Oral Laquinimod Reduced MS Relapses by 23%

Author:: Sherry Boschert

Publish date: April 13, 2011

Major Finding: Patients taking the investigational oral drug laquinimod reduced their annualized rate of multiple sclerosis relapse by 23% after 2...